<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02571114</url>
  </required_header>
  <id_info>
    <org_study_id>B2014:121</org_study_id>
    <nct_id>NCT02571114</nct_id>
  </id_info>
  <brief_title>Glycemic and Metabolic Responses of Frozen Yogurt Containing Saskatoon Berry Powder in Healthy Males and Females</brief_title>
  <official_title>A Randomized, Controlled Study to Examine the Glycemic and Metabolic Responses of Frozen Yogurt Containing Saskatoon Berry Powder in Healthy Males and Females</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Manitoba</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A single site, blinded, randomized, controlled study designed to examine the glycemic and
      metabolic response of frozen yogurt containing Saskatoon berry powder in healthy males and
      females.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A single site, blinded, randomized, controlled study designed to examine the glycemic and
      metabolic response of frozen yogurt containing Saskatoon berry powder in healthy males and
      females. Eligible participants will be asked to attend 4 in-person clinic visits for
      comparative testing of the frozen yogurt and frozen yogurt containing Saskatoon berry powder
      versus white bread. Separate visits for screening and for a fasting blood sample will also be
      requested (total of 6 visits).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum glucose</measure>
    <time_frame>180 min</time_frame>
    <description>glucometer readings of serum glucose at intervals after consumption of study foods</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>serum insulin</measure>
    <time_frame>180 min</time_frame>
    <description>serum insulin levels in response to consumption of study foods</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>metabolomics</measure>
    <time_frame>180 min</time_frame>
    <description>mass spectrometry analysis of serum and urine before and after consumption of study foods</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Control 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>white bread - 25 g available carbohydrate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>white bread - 25 g available carbohydrate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Frozen Yogurt</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>unflavoured frozen yogurt - 25 g available carbohydrate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saskatoon Berry Frozen Yogurt</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>frozen yogurt containing powder prepared from Saskatoon berries - 25 g available carbohydrate</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Saskatoon Berry Frozen Yogurt</intervention_name>
    <description>Frozen yogurt containing a defined amount of powder prepared from Saskatoon berries (serving size = 25 g available carbohydrate)</description>
    <arm_group_label>Saskatoon Berry Frozen Yogurt</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Frozen Yogurt</intervention_name>
    <description>Unflavoured frozen yogurt (serving size = 25 g available carbohydrate)</description>
    <arm_group_label>Frozen Yogurt</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control 1</intervention_name>
    <description>White bread (serving size = 25 g available carbohydrate)</description>
    <arm_group_label>Control 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control 2</intervention_name>
    <description>White bread (serving size = 25 g available carbohydrate)</description>
    <arm_group_label>Control 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male, or non-pregnant, non-lactating female, ≥18 and ≤35 years;

          2. Normal blood lipid profile, creatinine &lt;1.5× upper limit of normal (ULN) where the
             normal range is ≥7 units/L and ≤56 units/L, alanine aminotransferase (ALT) &lt;2× ULN
             where the normal range is ≥0.7 mg/dL and ≤1.3 mg/dL, and glycated hemoglobin &lt;6%;

          3. Blood pressure &lt;140/90

          4. Body mass index (BMI) ≥20 and &lt;30;

          5. Stable regime for the past 3 months if taking vitamin and mineral/dietary/ herbal
             supplements;

          6. Agree not to eat Saskatoon berries or foods containing Saskatoon berries while
             participating in this study;

          7. Willing to comply with the protocol requirements;

          8. Willing to provide informed consent.

        Exclusion Criteria:

          1. Not able to consume yogurt or allergies to Saskatoon berries or ingredients in yogurt
             or bread;

          2. Presence of a clinically diagnosed disease affecting the circulatory, respiratory,
             immune, skeletal, urinary, muscular, endocrine, digestive, nervous or reproductive
             system that requires medical treatment;

          3. Taking any prescribed medication in the last 3 months or supplements that affect
             gastrointestinal function in the last 3 months;

          4. Weight loss of ≥3 kg of body weight within the 6 months prior to enrolling in the
             study;

          5. Current (within the last month) bacterial, viral or fungal infection, or
             over-the-counter medication within the past 72 hours;

          6. Unable to obtain blood samples at the screening or the first study visit.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carla G Taylor, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Boniface Hospital, Asper Clinical Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Boniface Hospital, Asper Clinical Research Institute</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R2H 2A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2015</study_first_submitted>
  <study_first_submitted_qc>October 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2015</study_first_posted>
  <last_update_submitted>September 27, 2016</last_update_submitted>
  <last_update_submitted_qc>September 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glycemic Responses</keyword>
  <keyword>Metabolic Responses</keyword>
  <keyword>Males</keyword>
  <keyword>Females</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

